Company / Capital Expenditures
Ceribell, Inc. Capital Expenditures History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$767.0K
FY2025
5-year range
$767.0K / $983.0K
FY2023-FY2025
Trend
-22.0%
vs FY2024
Sector context
#147 of 150
Health Care
What the data says
Among 150 Health Care companies, Ceribell, Inc. is in the bottom 2% for capital expenditures. Declined from $983,000 to $767,000 over the past 2 years.
Based on SEC 10-K filings.
$767,000 in FY2025.
Declined from $983,000 to $767,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 150This company $767.0K Sector average $271.1M
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2025, capital expenditures decreased 22.0% year-over-year.
- Ranks #147 out of 150 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $767.0K | -22.0% |
| FY2024 | $983.0K | +0.0% |
| FY2023 | $983.0K | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026